Nicholas A Carpino

Title: The Innovations of Nicholas A Carpino

Introduction

Nicholas A Carpino is a notable inventor based in Memphis, TN (US). He has made significant contributions to the field of cancer research, particularly in understanding chronic myelogenous leukemia (CML). His work has implications for the development of targeted therapies for this type of cancer.

Latest Patents

Nicholas A Carpino holds a patent related to a human gene/protein involved in chronic myelogenous leukemia. The patent describes the chimeric p120^bcr-abl protein, which exhibits elevated protein tyrosine kinase activity compared to the normal c-abl tyrosine kinase. His research identifies a novel protein, p62^dok, which is associated with the p120 ras GTPase-activating protein (GAP) and plays a role in signal transduction pathways downstream of receptor tyrosine kinases.

Career Highlights

Throughout his career, Nicholas A Carpino has worked at prestigious institutions such as Cold Spring Harbor Laboratory and the Sloan-Kettering Institute for Cancer Research. His research has focused on the molecular mechanisms underlying CML, contributing to a better understanding of the disease.

Collaborations

Nicholas has collaborated with esteemed colleagues, including Ryuji Kobayashi and David G Wisniewski. These collaborations have furthered the research in the field of cancer biology and have led to advancements in therapeutic strategies.

Conclusion

Nicholas A Carpino's innovative work in cancer research, particularly regarding chronic myelogenous leukemia, highlights his contributions to the scientific community. His patent and collaborations reflect his commitment to advancing our understanding of cancer mechanisms and potential treatments.